| Literature DB >> 33822348 |
Johannes Oldenburg1, Robert Klamroth2, Florian Langer3, Manuela Albisetti4, Charis von Auer5, Cihan Ay6, Wolfgang Korte7, Rüdiger E Scharf8, Bernd Pötzsch1, Andreas Greinacher9.
Abstract
The COVID-19 pandemic is an ongoing global healthcare crisis. Based on reports of atypically located thromboses following vaccination with the AstraZeneca COVID-19 vaccine, the Society of Thrombosis and Haemostasis Research (GTH) has issued guidance statements on the recognition, diagnosis, and treatment of this rare complication. It shares pathophysiological features with heparin-induced thrombocytopenia (HIT) and is referred to as vaccine-induced prothrombotic immune thrombocytopenia (VIPIT). Thieme. All rights reserved.Entities:
Year: 2021 PMID: 33822348 DOI: 10.1055/a-1469-7481
Source DB: PubMed Journal: Hamostaseologie ISSN: 0720-9355 Impact factor: 1.778